SARS-CoV-2 Antigen Rapid Qualitative Test Type A

SARS-CoV-2 Antigen Rapid Qualitative Test Type B

HBP Rapid Quantitative Test (Chemiluminescence Immunoassay)

HBP Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Heparin binding protein (HBP) concentration in human plasma that contains Sodium Citrate samples, mainly used for auxiliary diagnosis of inflammation diseases.

Malaria P.f/Pan Antigen Rapid Test

The Malaria P.f/Pan Antigen Rapid Test is a rapid lateral flow immunoassay for the qualitative detection of Histidine-Rich Protein II (HRP-II) specific to Plasmodium falciparum (P.f) and Plasmodium lactate dehydrogenase (pLDH) specific to Plasmodium species (Pan) in human whole blood specimen. It is intended to be used by professionals as a screening test and provides a preliminary test result to aid in the diagnosis of infection with Malaria. For professional in vitro diagnostic use only.

NT-proBNP Rapid Quantitative Test (Chemiluminescence Immunoassay)

NT-proBNP Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the N-terminal pro-B-type natriuretic peptide（NT-proBNP） concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of cardiac diseases.

SARS-CoV-2 Antigen Rapid Qualitative Test Type B

NGAL Rapid Quantitative Test

NGAL (neutrophil gelatinase-associated lipocalin, lipocalin-2, sidero- calin) is a novel biomarker for diagnosing acute kidney injury (AKI). Under normal conditions NGAL levels are low in urine and plasma Still, they rise sharply from basal levels in response to kidney injury to reach diagnostic levels within a very short time - as much as 24 hours or more before any signiﬁcant rise in serum creatinine.

MAU Rapid Quantitative Test

MAU(Microalbumin) occurs when the kidney leaks small amounts of albumin into the urine, which is an early marker of kidney damage.

CLi-1600 CLIA Analyzer

CLi-1600 semi-automated device which quantifies biomarkers for thyroid disease, inflammation, cardiac diseases, fertility, diabetes, bone metabolism, anemia, and health check by analyzing human serum, plasma and whole blood.

Solutions

Covid-19 Solution

SARS-CoV-2 Antigen Rapid Test

SARS-CoV-2 Antigen Rapid Qualitative Test Type A